Anthropic ramps up biopharma push with Nobel hires and M&A plans

Anthropic, known for its artificial‑intelligence models, is expanding its focus to life sciences after a detailed internal memo outlined the move.

The memo, released in late 2024, named biology and neuroscience as priority areas and set a 100‑day sprint to build new capabilities.

The firm has started hiring top scientific talent, including recent recruitment of Nobel laureates, to accelerate its biopharma ambitions.

Anthropic is also looking at mergers and acquisitions to quickly gain expertise and data, marking a significant strategic shift toward biotech applications.